CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total Precipio, Inc. [Member]	Noncontrolling Interest in Joint Venture [Member]	Total
Balance at beginning of period at Dec. 31, 2019		$ 79,000	$ 74,065,000	$ (60,939,000)	$ 13,205,000		$ 13,205,000
Balance at beginning of period (in shares) at Dec. 31, 2019	47	7,898,117
Increase (Decrease) in Stockholders' Equity
Net loss				(10,625,000)	(10,625,000)	$ 27,000	(10,598,000)
Conversion of convertible notes into common stock		$ 39,000	2,137,000		2,176,000		2,176,000
Conversion of convertible notes into common stock (in shares)		3,908,145
Issuance of common stock in connection with purchase agreements		$ 58,000	8,871,000		8,929,000		8,929,000
Issuance of common stock in connection with purchase agreements (in shares)		5,770,654
Write-off beneficial conversion feature in conjunction with convertible note extinguishment			(523,000)		(523,000)		(523,000)
Write-off debt premiums (net of debt discounts) in conjunction with convertible note conversions			270,000		270,000		270,000
Non-cash Stock-based compensation			703,000		703,000		703,000
Balance at end of period at Dec. 31, 2020		$ 176,000	85,523,000	(71,564,000)	14,135,000	27,000	14,162,000
Balance at end of period (in shares) at Dec. 31, 2020	47	17,576,916
Increase (Decrease) in Stockholders' Equity
Net loss				(8,530,000)	(8,530,000)	13,000	(8,517,000)
Issuance of common stock in connection with purchase agreements		$ 5,000	1,255,000		1,260,000		1,260,000
Issuance of common stock in connection with purchase agreements (in shares)		500,000
Issuance of common stock in connection with at the market offering, net of issuance costs		$ 45,000	14,902,000		14,947,000		14,947,000
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)		4,501,000
Proceeds upon issuance of common stock from exercise of warrants		$ 1,000	399,000		400,000		400,000
Proceeds upon issuance of common stock from exercise of warrants (in shares)		74,000
Proceeds upon issuance of common stock from exercise of stock options		$ 3,000	3,000		3,000		3,000
Proceeds upon issuance of common stock from exercise of stock options (in shares)		1,379
Write-off warrant liability in conjunction with warrant exercises			320,000		320,000		320,000
Issuance of common stock for consulting services		$ 200,000	150,000		150,000		150,000
Issuance of common stock for consulting services (in shares)		55,147
Non-cash Stock-based compensation			1,879,000		1,879,000		1,879,000
Balance at end of period at Dec. 31, 2021		$ 227,000	$ 104,431,000	$ (80,094,000)	$ 24,564,000	$ 40,000	$ 24,604,000
Balance at end of period (in shares) at Dec. 31, 2021	47	22,708,442